Edward White
Stock Analyst at HC Wainwright & Co.
(1.47)
# 3,592
Out of 5,241 analysts
338
Total ratings
29.97%
Success rate
-8.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $15.73 | +109.79% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $5.72 | +197.20% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $3.08 | +387.01% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.70 | +62.16% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $0.49 | +3,163.97% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.73 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $20.43 | +291.58% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.39 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $9.78 | +104.50% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $4.78 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.58 | +346.93% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $7.74 | +223.00% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.47 | +223.89% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $17.74 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.68 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $39.50 | +39.24% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $20.23 | +152.10% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $6.92 | +1.16% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $7.67 | +630.12% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | $10.28 | +405.84% | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.80 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $28.21 | +6.35% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.76 | +583.76% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $15.73
Upside: +109.79%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $5.72
Upside: +197.20%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $3.08
Upside: +387.01%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.70
Upside: +62.16%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $0.49
Upside: +3,163.97%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.73
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $20.43
Upside: +291.58%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.39
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $9.78
Upside: +104.50%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.78
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.58
Upside: +346.93%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $7.74
Upside: +223.00%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $2.47
Upside: +223.89%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $17.74
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.68
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $39.50
Upside: +39.24%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $20.23
Upside: +152.10%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $6.92
Upside: +1.16%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $7.67
Upside: +630.12%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: $10.28
Upside: +405.84%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.80
Upside: -
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $28.21
Upside: +6.35%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.76
Upside: +583.76%